Expiring patents, the rise of generic competition, growth of more specialized and personalized medicine, and the fall of blockbuster drugs have caused the industry to change. What was once an industry almost solely reliant on corporate resources is now made up of broad and heavily interconnected ecosystems of partners, vendors and affiliates. In a nutshell: collaboration is now an essential part of life sciences operations.
